Skip to main content

Thermo Fisher Scientific Inc.

corporate_fare Company Profile

Thermo Fisher Scientific Inc.

TMO·NYSE·Industrial Applications And Services·CIK 0000097745

Thermo Fisher Scientific Inc. is the world leader in serving science, aiming to enable customers to make the world healthier, cleaner, and safer. The company serves customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental, industrial, research and development, quality, and process control settings. Thermo Fisher delivers innovative technologies, purchasing convenience, and pharmaceutical services through brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. The company expands its capabilities through organic investments in research and development, capacity, and acquisitions. Thermo Fisher reports its business in four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments, and consumables for biological and medical research, drug and vaccine discovery and production, and disease diagnosis. These products and services are used by customers in pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. This segment includes three primary businesses: biosciences, genetic sciences, and bioproduction. The biosciences business offers reagents, instruments, and consumables for biological and medical research in areas like molecular biology and protein biology, new drug and vaccine discovery, and disease diagnosis.

Thermo Fisher Scientific Inc. (NYSE:TMO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for TMO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for TMO spans 10-Q, 8-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • Thermo Fisher Board Clears New $5B Buyback, Replacing $1B Remaining Authorization
  • Thermo Fisher 10-Q Details Q3 GAAP EPS $4.64, $244M Held-for-Sale Loss, $180M More Restructuring
  • Thermo Fisher Beats Q3, Lifts 2026 EPS and Sales Guidance
  • Thermo Fisher Posts Q3 EPS of $4.64
  • Thermo Fisher Q2 2026: Revenue Reaches $11.99B, Clario Deal Closes, Microbiology Unit Sold

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$44.56B
Net Income
$6.7B
Diluted EPS
$17.74
Op. Cash Flow
$7.82B
Free Cash Flow
$6.29B
Operating Income
$7.75B
Cash & Equivalents
$9.85B
Total Debt
$42.7B
Debt / Equity
0.80×
Net Margin
15.0%
Shares Outstanding
377M sh
Source: 10-K · filed 2026-02-26 · accession 0000097745-26-000018

Short Interest & Short Volume

1.97 days to cover

FINRA reported short interest of 4,784,430 shares in TMO as of the October 30, 2026 settlement, a 2.1% decrease from the prior period — about 2.0 days to cover at its recent average daily volume. On November 20, 2026, 50.8% of TMO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,784,430 shares as of October 30, 2026
Change vs prior period▼ 2.1%
Days to cover1.97 at avg daily volume of 2,429,097
Daily short volume (FINRA facilities)50.8% of 862,048 shares on November 20, 2026
5-day average short volume49.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with T →
$673.5 +0.59% today
52-week range · as of 2026-10-30 $435.27 – $711.85
Market cap
$248.08B
Volume
2.4M (1.1× avg)
3-mo avg 2.2M
Live data · 2026-11-22 12:31 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TMO - Latest Insights

TMO
Nov 06, 2026, 10:21 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $686.10
Real-time Price: $673.50 info
Change: -$12.60 (-2%) info
Market Cap: $248.075B info
TMO
Oct 30, 2026, 10:52 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $699.82
Real-time Price: $673.50 info
Change: -$26.32 (-4%) info
Market Cap: $248.075B info
TMO
Oct 21, 2026, 2:31 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $696.57
Real-time Price: $673.50 info
Change: -$23.07 (-3%) info
Market Cap: $248.075B info
TMO
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $690.00
Real-time Price: $673.50 info
Change: -$16.50 (-2%) info
Market Cap: $248.075B info
TMO
Jul 31, 2026, 10:51 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $564.80
Real-time Price: $673.50 info
Change: +$108.70 (+19%) info
Market Cap: $248.075B info
TMO
Jul 23, 2026, 6:04 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $547.00
Real-time Price: $673.50 info
Change: +$126.50 (+23%) info
Market Cap: $248.075B info
TMO
Jul 23, 2026, 6:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $550.00
Real-time Price: $673.50 info
Change: +$123.50 (+22%) info
Market Cap: $248.075B info
TMO
May 26, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $449.00
Real-time Price: $673.50 info
Change: +$224.50 (+50%) info
Market Cap: $248.075B info
TMO
May 20, 2026, 8:50 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $450.56
Real-time Price: $673.50 info
Change: +$222.94 (+49%) info
Market Cap: $248.075B info
TMO
May 11, 2026, 7:30 AM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $468.50
Real-time Price: $673.50 info
Change: +$205.00 (+44%) info
Market Cap: $248.075B info
TMO
May 01, 2026, 11:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $472.21
Real-time Price: $673.50 info
Change: +$201.29 (+43%) info
Market Cap: $248.075B info
TMO
Apr 23, 2026, 11:43 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $460.80
Real-time Price: $673.50 info
Change: +$212.70 (+46%) info
Market Cap: $248.075B info
TMO
Apr 23, 2026, 6:09 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $501.00
Real-time Price: $673.50 info
Change: +$172.50 (+34%) info
Market Cap: $248.075B info
TMO
Apr 23, 2026, 6:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $499.39
Real-time Price: $673.50 info
Change: +$174.11 (+35%) info
Market Cap: $248.075B info
TMO
Apr 07, 2026, 8:14 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $488.25
Real-time Price: $673.50 info
Change: +$185.25 (+38%) info
Market Cap: $248.075B info
TMO
Mar 24, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $478.40
Real-time Price: $673.50 info
Change: +$195.10 (+41%) info
Market Cap: $248.075B info
TMO
Mar 24, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $478.40
Real-time Price: $673.50 info
Change: +$195.10 (+41%) info
Market Cap: $248.075B info
TMO
Feb 26, 2026, 12:11 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $513.99
Real-time Price: $673.50 info
Change: +$159.51 (+31%) info
Market Cap: $248.075B info
TMO
Feb 09, 2026, 5:25 PM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $546.76
Real-time Price: $673.50 info
Change: +$126.74 (+23%) info
Market Cap: $248.075B info
TMO
Jan 29, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $614.41
Real-time Price: $673.50 info
Change: +$59.09 (+10%) info
Market Cap: $248.075B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets